leisure time -WSS

leisure time

author：leisure time 2025-09-04 22:01:56 - browse：16

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

focus

WSS

A deep dive into Applied Therapeutics’ data, and questions on Cassava

IVF, abortion rights issues kick off Biden’s State of the Union

Bird flu in dairy cattle: New measures to control spread to humans

Researchers test human milk's ability to repair gut microbiome

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Harvard scientists, with Google, unveil the most detailed brain map ever

focus

leisure time

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Drug repurposing or repositioning? The language matters

Change Healthcare cyberattack prompts Medicare loan program

Bright Health sells Medicare Advantage business to Molina

People with mental disorders often marry others with same

What does generative AI mean for health care? We asked experts

The drug industry has found itself all alone in Washington

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

CDC marks new Covid

Malaria cases in Florida and Texas: Here’s what you need to know

In his State of the Union, Biden takes clear aim at 'Big Pharma'

knowledge

Amylyx ALS drug failure raises questions and concerns

Trial using CRISPR to edit HIV out of cells disappoints

NEJM study link tiny plastics in blood vessels to heart problems

RSV shot was 90% effective at preventing hospitalizations in kids

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

Bird flu reported in person exposed to presumably infected cattle

focus

focus

focus

explore